IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q2 2025 Holdings

Filed 2025-08-12 | 11 holdings | $662.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$213.7M4,896,46232.3%
Disc Medicine, Inc.(IRON)Common Stock254604101$126.3M2,384,45619.1%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$86.9M9,130,46513.1%
Sionna Therapeutics, Inc.(SION)Common Stock829401108$64.1M3,694,0209.7%
Third Harmonic Bio, Inc.(THRD)Common Stock88427A107$56.5M10,402,2868.5%
Vigil Neuroscience, Inc.(VIGL)Common Stock92673K108$46.4M5,836,8747.0%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$41.8M6,430,2576.3%
Korro Bio, Inc.(KRRO)Common Stock500946108$14.2M1,137,1492.1%
Ikena Oncology, Inc.Common Stock45175G108$6.7M5,018,1781.0%
Q32 Bio, Inc.(QTTB)Common Stock746964105$3.1M2,092,1060.5%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$2.7M8,279,4840.4%